271 related articles for article (PubMed ID: 35513212)
1. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
5. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
6. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
7. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
8. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
10. An iron-containing ferritin-based nanosensitizer for synergistic ferroptosis/sono-photodynamic cancer therapy.
Zheng Y; Zheng J; Du M; Yang Y; Li X; Chen H; Gao Y
J Mater Chem B; 2023 Jun; 11(22):4958-4971. PubMed ID: 37203438
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
Nie T; Zou W; Meng Z; Wang L; Ying T; Cai X; Wu J; Zheng Y; Hu B
Adv Mater; 2022 Nov; 34(45):e2206286. PubMed ID: 36134532
[TBL] [Abstract][Full Text] [Related]
12. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
13. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer
Tao W; Wang N; Ruan J; Cheng X; Fan L; Zhang P; Lu C; Hu Y; Che C; Sun D; Duan J; Zhao M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6404-6416. PubMed ID: 35077153
[No Abstract] [Full Text] [Related]
15. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.
Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S
Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753
[TBL] [Abstract][Full Text] [Related]
16. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
[TBL] [Abstract][Full Text] [Related]
18. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
19. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification.
Feng W; Shi W; Wang Z; Cui Y; Shao X; Liu S; Rong L; Liu Y; Zhang H
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37540-37552. PubMed ID: 35944147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]